Phase II Trial to Evaluate the Efficacy and Safety of the Combination of Obinutuzumab and Bendamustine Treatment in Patients (Pts) with Relapsed/Refractory Chronic Lymphocytic Leukemia (CLL)

Authors: Garcia-Marco, Jose, Baltasar Tello, Patricia ^*, Garcia, Esther González ^*, Ríos Herranz, Eduardo ^*, Ramirez Payer, Angel ^*, Terol Castera, María José ^*, Champ, Diana ^*, Medina Perez, Angeles ^*, Gironella, Mercedes ^*, Rodríguez Fernández, Alicia ^*, Muntañola Prat, Ana ^*, Suárez Cabrera, Alexia ^*, Jurado Chacón, Manuel ^*, Fernández Zarzoso, Miguel ^*, Rodríguez, Mercedes ^*, Clavel, Juana ^*, Dourdil Sahun, Maria Victoria ^*, Ferra Coll, Christelle M ^*, Pérez Persona, Ernesto ^*, Marrero Santos, Carmen Milagros ^*, Forés, Rafael ^*, Delgado, Julio

Source: In Blood 8 December 2017 130 Supplement 1:4321-4321